| Filed On | Filing |
|---|---|
| 20 Nov 2023 | Form 3: Himmelreich Jeffrey C, Head of Finance |
| 23 Mar 2023 |
Form 3: Theagene Jean-Manasse, Director
No securities owned |
| 27 Jul 2022 |
Form 3: Gryaznov Sergei, Chief Scientific Officer
Holds 21,511 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Chaouki Steven M, Director
Holds 41,250 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Louie Ngar Yee, Director
Holds 908,584 shares of Common Stock |
| 27 Jul 2022 | Form 3: Mcguire Joseph F, Chief Financial Officer |
| 27 Jul 2022 |
Form 3: Vitoc Vlad, Director
Holds 783,121 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Obrocea Mihail, Chief Medical Officer
Holds 26,100 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Guerrero Ramiro, Director
Holds 259,382 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Luput Cristian, Director
Holds 277,568 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Vlad Laurentiu, Director
Holds 371,933 shares of Common Stock |
| 27 Jul 2022 |
Form 3: Smith Stan, Director
Holds 296,128 shares of Common Stock |
Loading...